Neurozen (뉴로젠)
Gangnam, South Korea
Neurozen is dedicated to developing advanced, deep learning-enabled neuroimaging and genetic solutions for the risk assessment and early detection of Alzheimer’s disease. Risk assessment and early detection are crucial to helping target the disease before irreversible brain damage or mental decline has occurred. Our mission is to provide innovative, quality clinical tools to predict, quantify, and monitor neurodegeneration as well as so that physicians can be more confident in making important clinical decisions and people can enjoy a higher quality of life.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2015
- Website
- neurozen.ai/
Only accessible to MedStartr community members.
Join nowWhat do you think of Neurozen (뉴로젠)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now